RESUMO
Public policy decisions about patients' access to limited healthcare resources must be defensible and responsive to the interests of those affected. Decision-makers should articulate their reasoning and recommendations so that citizens can judge them. While the context of policy decisions will differ, their legitimacy depends upon the transparency of the reasoning, the accountability of the decision-makers, the testability of the evidence used to inform the decision-making and the inclusive recognition of those the decision affects. An example of applying this framework to resource allocation is that of approving effective high-cost anticancer drugs in a timely fashion.
Assuntos
Tomada de Decisões , Ética Médica , Política de Saúde , Alocação de Recursos , Antineoplásicos/economia , Austrália , Custos de Medicamentos , Recursos em Saúde , Humanos , Formulação de Políticas , Responsabilidade SocialRESUMO
Appropriate ethical oversight underpins the conduct of all clinical trials in Australia. In addition, clinical trials require a suitable approach to research governance in order to ensure that research is appropriately governed. However, such governance processes are often onerous and time-consuming and are not required when trial practices are more appropriately understood as standard of care clinical services.